EBITDA grew by 23% in the second half of the year,bringing full-year EBITDA to US$1.1billion at a margin of 10%.
Feb 27, 2025
Newly Patented Technology Improves Policy Research and Compliance Monitoring CODIT Enhances Legislative Intelligence Offerings with U.S. Patent Recognition
Feb 27, 2025
HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c
Feb 26, 2025
TOKYO,Feb. 25,2025-- GENERAL LINK Inc. has announced an exciting new campaign starting March 1st,2025,aimed at overseas travelers visiting Japan. The campaign will offer free optionsatGL Terrace, a lu
Feb 26, 2025
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
Feb 26, 2025
ASHBURN,VA,Feb. 25,2025-- DXC Technology,(NYSE: DXC),a leading Fortune 500 global technology services provider,has signed an agreement with Skanska AB,a multinational construction and project developm
Feb 26, 2025
The smartest AI global HR advisor,G-P Gia,thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states
Feb 26, 2025
XUZHOU,China,Feb. 25,2025--The 3rd XCMG & FinDreams Super Battery Day was successfully held at the XCMG International Conference Center,Xuzhou,focused on cutting-edge technologies and explored new
Feb 26, 2025
A survey of 2,000 bank customers reveals that 84% are likely to switch banks to access services that help them reach their financial goals
Feb 26, 2025
SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo
Feb 26, 2025
Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of
Feb 26, 2025
HEFEI,China,Feb. 25,2025-- Kangpu Biopharmaceuticals,Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National M
Feb 26, 2025
Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News
© Singapore Technology Information Privacy Policy Contact us